artificial-intelligence
-
The Leadership Timing Paradox Inside MedTech Scale-Ups
Most MedTech companies do not lose momentum because they chose the wrong leaders. They lose momentum because the company entered a new phase before the leadership structure changed with it. This is the leadership timing paradox. This short video explains why leadership timing risk rarely appears as failure first. It usually appears as lost momentum…
ai, artificial-intelligence, business, clinical to commercial transition leadership, executive alignment medtech scaling, leadership, leadership risk medtech scaleups, leadership timing risk medtech, medtech commercialisation leadership structure, medtech governance readiness, medtech leadership transitions, medtech scaleup governance strategy, phase transition leadership risk, portfolio chair medtech leadership risk, right leader wrong phase medtech, series a medtech leadership readiness, technology
-
Why Good Boards Are Often Late to the Real Conversation
Most MedTech boards are not late because they are inattentive. They are late because they are responsible. That distinction matters more than it first appears. Boards exist to move organisations forward with confidence, not to reopen every decision once it has been prepared, reviewed, and presented. By the time something reaches the agenda, it is…
-
When Progress Quietly Reduces Your Options
Progress feels a little like driving on a motorway. When the road is clear and the car is moving quickly, it is natural to assume you have plenty of options. After all, you are travelling faster and covering more ground than before. But there is a small paradox in motorway driving that anyone who has…
-
Why Boards Often Realise the Value of a CMO Too Late
Clinical leadership in MedTech is rarely treated as a strategic variable at the start. In early stages, it often appears procedural. A role associated with compliance, trials, and regulatory navigation. Certainly treated as important but not always central to valuation. That perception tends to change when the inevitable pressure mounts. As scale approaches, clinical judgement…
-
When Boards Confuse Assurance With Control
Boards rarely seek control for its own sake. They seek reassurance that control exists. In regulated MedTech environments, that instinct is responsible. Decisions carry consequences, timelines compound exposure, and oversight is not optional. Assurance is how boards demonstrate care without pretending certainty is possible. The difficulty begins when assurance quietly takes on a second role.…
-
How Boards Misread Technical Risk
When Everything Sounds Reasonable Most boards believe they have good visibility on technical risk. They usually do, just not early enough. In well‑run MedTech organisations, risk almost never shows up as failure first. What it shows up as is reassurance. Milestones are being hit. The team sounds confident when they talk it through. The board…
ai, artificial-intelligence, Board oversight of engineering risk, business, Early vs late technical risk decisions, How boards assess technical risk in MedTech, How MDR and IVDR exposed governance gaps, Leadership alignment MedTech, MedTech board governance, MedTech board oversight, MedTech technical risk, Regulatory risk MedTech, Technical leadership risk, Technical risk governance, Technical risk in regulated healthcare, Technical risk visibility at board level, technology, Why MedTech boards miss early technical risk
-
The Leadership Gap MedTech Will Feel Before It Can Measure
In the coming years, many MedTech organisations will experience delays, friction, and regulatory setbacks that do not feel like failures. They will feel like bad luck. A certification that takes longer than expected. A product that stalls late in development. A launch window that quietly slips. In most cases, the root cause will not be…
ai, artificial-intelligence, business, CTO, How boards assess technical leadership, How MedTech leadership decisions affect regulation, leadership, Leadership risk in regulated healthcare, Leadership Strategy, management, MedTech, MedTech board advisory, MedTech CMO recruitment, MedTech CTO recruitment, MedTech executive hiring, MedTech leadership, MedTech leadership risk, Regulated MedTech leadership, Senior technical leadership MedTech, Tech Leadership, technology, Why MedTech hiring fails at senior level, Why MedTech launches get delayed
-
The Gap Between How AI Is Built and How It Will Be Assessed
Most AI MedTech companies are doing the right things, just in a way regulators will not recognise. Internally, everything feels controlled; externally, it will be judged by a very different standard. That gap widens fastest in companies moving quickly, led by capable teams who assume alignment will catch up later. But it rarely does. How…
Harun Rabbani 